|Day's Range||77.7200 - 78.3500|
|52 Week Range||64.1800 - 86.7200|
|PE Ratio (TTM)||37.74|
|Dividend & Yield||2.08 (2.66%)|
|1y Target Est||N/A|
The 2017 annual meeting of the American Society of Clinical Oncology (ASCO) runs from June 2 to June 6. The following companies have signaled that they will be presenting data, or data will be presented ...
Merck (MRK) got another approval for Keytruda while Aerie shot up on positive data.
In 1Q17, Amgen’s (AMGN) Nplate generated revenues of ~$154 million, which reflected a year-over-year growth rate of 9%.